Skip to main content
SpringerLink
Log in

Pegaspargase (Polyethylene Glycol-L-Asparaginase)

A Viewpoint by Joachim Boos and Herbert Jürgens

  • New Drug Profile
  • Guest Commentary
  • Published:
Clinical Immunotherapeutics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Asselin BL, Whitin JC, Coppola DJ, et al. Comparative pharmacokinetic studies of three asparaginase preparations. J Clin Oncol 1993 Sep; 11(9): 1780–6

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Hematology/Oncology, University of Münster, Münster, Germany

    Joachim Boos & Herbert Jürgens

Authors
  1. Joachim Boos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Herbert Jürgens
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boos, J., Jürgens, H. Pegaspargase (Polyethylene Glycol-L-Asparaginase). Clin. Immunother. 5, 497–498 (1996). https://doi.org/10.1007/BF03259347

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259347

Keywords

Search

Navigation